What is AVNS's dilution risk score?

AVNS has a latest available DilutionScore record of 23/100, categorized as low dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for AVNS, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for AVNS?

DilutionWatch tracks 25 SEC filing types for AVNS including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect AVNS shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For AVNS, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for AVNS tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for AVNS. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

AVNS Dilution Risk Score: 23/100 (LOW)

Score Breakdown

📋 Offering Ability

40

💰 Cash Runway

0

📊 Float Risk

10

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for AVNS.

🔔 Track AVNS — Get forecast alerts →

Market Data

Market Cap$1.16B

Shares Outstanding46.82M

Float45.61M

Cash$65.60M

Debt$226.30M

Short InterestN/A

Institutional Holdings

QoQ: ↓ 19.5% shares (2026Q1 vs prior)

259 institutional holders · 50.30M shares

#1 BlackRock, Inc. 6.84M shares

#2 T. Rowe Price Investment Management, Inc. 5.33M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 3.94M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.75M

Days to Cover2.4

% of Float3.8%

FINRA data as of Jul 15, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

4 INSIDER TRANSACTION 2026-03-17

4 INSIDER TRANSACTION 2026-03-11

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual AVNS Dilution Snapshot

Avanos Medical, Inc. (AVNS) has a DilutionScore of 23/100, rated Low dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for AVNS: 4 on 2026-03-17; 4 on 2026-03-17; 4 on 2026-03-17.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

More Research for AVNS

AVNS FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

AVNS — Avanos Medical, Inc. Dilution Risk Tracker